English | Español

Pharmaceuticals

+ Pharmaceuticals
Patient Daily | Jul 22, 2026

Novartis and Johnson & Johnson begin Q2 earnings as biopharma IPOs continue
+ Pharmaceuticals
Patient Daily | Jul 22, 2026

AI data becomes a key issue in biopharma deal negotiations
+ Pharmaceuticals
Patient Daily | Jul 22, 2026

Summit and Akeso report new Western data on ivonescimab in lung cancer trial
+ Pharmaceuticals
Patient Daily | Jul 22, 2026

Experimental neurointerventional technique shows promise for severe back pain
+ Pharmaceuticals
Patient Daily | Jul 22, 2026

Repligen announces $1.5 billion acquisition of BioLife Solutions for cell therapy products
+ Pharmaceuticals
Patient Daily | Jul 22, 2026

Survey shows many Americans uncertain about CDC pregnancy vaccine recommendations
+ Pharmaceuticals
Patient Daily | Jul 22, 2026

Study links higher red meat intake to increased pancreatic cancer risk
+ Pharmaceuticals
Patient Daily | Jul 22, 2026

Transitioning from large pharmaceutical firms to specialty pharma shifts focus to patient proximity

Trending
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update
+ Regulatory
M. Y. Bailey | Aug 7, 2026

PhRMA's Zirkelbach: 340B program has changed dramatically with 'little transparency into how patients benefit'
Patient Daily reports | Aug 10, 2026

SoCal Breathe Free warns persistent sinus symptoms may signal chronic inflammation